NCT02504333
- Conditions
- Metastatic Pancreatic Adenocarcinoma
- Locations
-
- Spanish Cooperative for Digestive Tumour Therapy (TTD) Madrid, Spain
Clinical trial condition
Metastatic Pancreatic Adenocarcinoma
Explore clinical trials studying Metastatic Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.
80 public trials
12 recruiting studies
Metastatic Pancreatic Adenocarcinoma trial results
NCT04050085
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT02324543
- Conditions
- Metastatic Pancreatic Adenocarcinoma
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT02333188
- Conditions
- Adenocarcinoma, Adenocarcinoma of Unknown Primary, Adult Cholangiocarcinoma, +35 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- NorthShore University Health System Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
NCT02620865
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
- Locations
-
- Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
- Conditions
- Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7, +1 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Case Western Reserve University Cleveland, Ohio, United States
- University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT03331562
- Conditions
- Advanced Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- The University of Kansas Cancer Center Westwood, Kansas, United States
- Atlantic Medical Group-Oncology Morristown Medical Center Morristown, New Jersey, United States
NCT03214250
- Conditions
- Metastatic Pancreatic Adenocarcinoma
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- Stanford University Stanford, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT02227940
- Conditions
- ALK Positive, Advanced Malignant Solid Neoplasm, Digestive System Diseases, +10 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
NCT02562898
- Conditions
- Metastatic Pancreatic Adenocarcinoma
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Oregon Health and Science University Portland, Oregon, United States